Ablynx NV IPO Research Information

Ablynx NV IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Ablynx NV, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Ablynx NV	ABLX - NASDAQ	$17.90-$19.08	$17.50	$17.85	11.43 million ADSs	10/25/2017
Underwriter(s): BofA Merrill Lynch, J.P. Morgan, Jefferies
Co-Manager(s): Baird, Bryan Garnier & Co., Ladenburg Thalmann
Industry: Health Care
Filing(s): Terms Added 2017-10-17 Filed 2017-10-02 Updated Terms 2017-10-20 Final Prospectus 2017-10-25

Ablynx NV Quote & Chart - Click for current quote - ABLX

About Ablynx NV (adapted from Ablynx NV prospectus):
They are a late-stage clinical biopharmaceutical company utilizing our proprietary Nanobody platform to develop treatments for a broad range of therapeutic indications with an unmet medical need. Their ordinary shares are listed on Euronext Brussels under the symbol 'ABLX'.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ABLX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.